Company press releases

Displaying 51 - 92 of 92 results
Released Company Title Industry Topic
11 May 2023
18:00 CEST 		EUROAPI SA EUROAPI : Assemblée Générale Mixte du 11 mai 2023 20103015 Pharmaceuticals Other subject
11 May 2023
18:00 CEST 		EUROAPI SA EUROAPI: Combined General Meeting of May 11, 2023 20103015 Pharmaceuticals Other subject
10 May 2023
20:18 CEST 		EUROAPI SA EUROAPI’s Board of Directors Proposes Géraldine Leveau as Director 20103015 Pharmaceuticals Other subject
10 May 2023
20:18 CEST 		EUROAPI SA Le Conseil d’administration d’EUROAPI propose Géraldine Leveau en tant qu’administrateur 20103015 Pharmaceuticals Other subject
09 May 2023
07:00 CEST 		EUROAPI SA EUROAPI and Novéal sign CDMO agreement to advance cosmetic projects 20103015 Pharmaceuticals Other subject
09 May 2023
07:00 CEST 		EUROAPI SA EUROAPI et Novéal signent un accord de CDMO pour des projets dans le domaine de la cosmétique 20103015 Pharmaceuticals Other subject
26 Apr 2023
18:00 CEST 		EUROAPI SA EUROAPI: Availability of the Amendment n°1 of the 2022 Universal Registration Document 20103015 Pharmaceuticals Other subject
26 Apr 2023
18:00 CEST 		EUROAPI SA EUROAPI : Mise à disposition de l’Amendement n°1 du Document d’Enregistrement Universel 2022 20103015 Pharmaceuticals Other subject
14 Apr 2023
23:00 CEST 		EUROAPI SA EUROAPI: Availability of the 2022 Universal Registration Document, Including the Annual Financial Report 20103015 Pharmaceuticals Other subject
14 Apr 2023
23:00 CEST 		EUROAPI SA EUROAPI : Mise à disposition du Document d’Enregistrement Universel 2022, contenant le Rapport Financier Annuel 20103015 Pharmaceuticals Other subject
08 Mar 2023
07:00 CET 		EUROAPI SA EUROAPI: Full-Year 2022 Results 20103015 Pharmaceuticals Other subject
08 Mar 2023
07:00 CET 		EUROAPI SA EUROAPI : RESULTATS ANNUELS 2022 20103015 Pharmaceuticals Other subject
31 Jan 2023
07:00 CET 		EUROAPI SA EUROAPI: Progressive restart of prostaglandin production at Budapest site 20103015 Pharmaceuticals Other subject
31 Jan 2023
07:00 CET 		EUROAPI SA EUROAPI : Redémarrage progressif de la production de prostaglandines sur le site de Budapest 20103015 Pharmaceuticals Other subject
11 Jan 2023
18:00 CET 		EUROAPI SA EUROAPI’s Board of Directors Proposes Mattias Perjos as Independent Director 20103015 Pharmaceuticals Other subject
11 Jan 2023
18:00 CET 		EUROAPI SA Le Conseil d’administration d’EUROAPI propose Mattias Perjos en tant qu’administrateur indépendant 20103015 Pharmaceuticals Other subject
09 Jan 2023
07:00 CET 		EUROAPI SA Vitamine B12 : EUROAPI va investir 40 millions d’euros dans un procédé de production plus efficace et durable en France 20103015 Pharmaceuticals Other subject
09 Jan 2023
07:00 CET 		EUROAPI SA Vitamin B12: EUROAPI to Invest €40 Million for a More Efficient and Sustainable Production Process in France 20103015 Pharmaceuticals Other subject
07 Dec 2022
07:00 CET 		EUROAPI SA  EUROAPI actualise ses prévisions financières 2022 20103015 Pharmaceuticals Other subject
07 Dec 2022
07:00 CET 		EUROAPI SA EUROAPI Updates Its 2022 Financial Guidance 20103015 Pharmaceuticals Other subject
31 Oct 2022
18:00 CET 		EUROAPI SA EUROAPI va porter les capacités de fabrication de peptides et d’oligonucléotides de son site de Francfort à 500 kg par an d’ici à 2025 20103015 Pharmaceuticals Other subject
31 Oct 2022
18:00 CET 		EUROAPI SA EUROAPI to Reach 500 kg Peptide and Oligonucleotide Capacity Per Year in Frankfurt by 2025 20103015 Pharmaceuticals Other subject
01 Sep 2022
07:30 CEST 		EUROAPI SA EUROAPI: Availability of 2022 Half-Year Financial Report 20103015 Pharmaceuticals Other subject
01 Sep 2022
07:30 CEST 		EUROAPI SA EUROAPI : Mise à disposition du Rapport financier semestriel 2022 20103015 Pharmaceuticals Other subject
01 Sep 2022
07:00 CEST 		EUROAPI SA EUROAPI: Solid Business and Financial Performance in H1-2022 - Net Sales and Core EBITDA Margin Guidance for 2022 Confirmed 20103015 Pharmaceuticals Other subject
01 Sep 2022
07:00 CEST 		EUROAPI SA EUROAPI : Solide performance opérationnelle et financière au S1-2022 - Objectifs annuels 2022 de chiffre d’affaires et de marge de Core EBITDA confirmés 20103015 Pharmaceuticals Other subject
22 Jul 2022
07:00 CEST 		EUROAPI SA EUROAPI Announces the Success of Its First Global Employee Share Plan “EUROAPI Action 2022” 20103015 Pharmaceuticals Other subject
22 Jul 2022
07:00 CEST 		EUROAPI SA EUROAPI annonce le succès de son premier plan mondial d’actionnariat salarié « EUROAPI Action 2022 » 20103015 Pharmaceuticals Other subject
21 Jul 2022
07:00 CEST 		EUROAPI SA ESG: EUROAPI Moves Forward With Its Carbon Reduction Ambition and Invests to Build a State-of-the-Art Biomass Boiler in France 20103015 Pharmaceuticals Other subject
21 Jul 2022
07:00 CEST 		EUROAPI SA ESG : EUROAPI poursuit son ambition de réduction de ses émissions de carbone et investit dans la construction d’une chaufferie biomasse de pointe en France 20103015 Pharmaceuticals Other subject
01 Jul 2022
18:00 CEST 		EUROAPI SA Availability of EUROAPI’s 2021 Half-Year Results 20103015 Pharmaceuticals Other subject
01 Jul 2022
18:00 CEST 		EUROAPI SA Mise à disposition des résultats semestriels 2021 d’EUROAPI 20103015 Pharmaceuticals Other subject
09 Jun 2022
20:20 CEST 		EUROAPI SA EUROAPI rejoint les indices SBF 120 et CAC Mid 60 20103015 Pharmaceuticals Other subject
09 Jun 2022
20:20 CEST 		EUROAPI SA EUROAPI joins the SBF 120 and CAC Mid 60 indices 20103015 Pharmaceuticals Other subject
03 Jun 2022
18:30 CEST 		EUROAPI SA EUROAPI lance son premier plan mondial d’actionnariat salarié EUROAPI Action 2022 20103015 Pharmaceuticals Other subject
03 Jun 2022
18:30 CEST 		EUROAPI SA EUROAPI launches its first global employee share plan “EUROAPI Action 2022” 20103015 Pharmaceuticals Other subject
01 Jun 2022
07:00 CEST 		EUROAPI SA EUROAPI met en œuvre un contrat de liquidité avec Kepler Cheuvreux 20103015 Pharmaceuticals Other subject
01 Jun 2022
07:00 CEST 		EUROAPI SA EUROAPI Implements a Liquidity Contract With Kepler Cheuvreux 20103015 Pharmaceuticals Other subject
30 May 2022
07:00 CEST 		EUROAPI SA CDMO: EUROAPI Supports Sanofi’s mRNA Vaccine Platform with the Development of Lipid Nanoparticles 20103015 Pharmaceuticals Other subject
30 May 2022
07:00 CEST 		EUROAPI SA CDMO : EUROAPI soutient la plateforme de vaccins à ARNm de Sanofi grâce au développement de nanoparticules lipidiques 20103015 Pharmaceuticals Other subject
06 May 2022
12:18 CEST 		EUROAPI SA EUROAPI Announces Its Successful Listing on Euronext Paris 20103015 Pharmaceuticals Share history
06 May 2022
12:18 CEST 		EUROAPI SA EUROAPI annonce le succès de sa cotation sur Euronext Paris 20103015 Pharmaceuticals Share history